Rapid changes in night eating: Considering mechanisms

Eating and Weight Disorders

Volumn 15, Issue 1-2, 2010, Pages

  Stunkard, Albert ^a   Lu, X Y ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Glucocorticoid system; Melanocortin system; Neuroendocrine factors; Night Eating Syndrome (NES); Selective serotonin reuptake inhibitors (SSRIs); Serotonergic system

Indexed keywords

CARBOHYDRATE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FAT; GHRELIN; GLUCOCORTICOID; HYDROCORTISONE; INSULIN; LEPTIN; MELANOCORTIN; MELATONIN; PROLACTIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; THYROTROPIN;

ACCELEROMETRY; ANXIETY; BARIATRIC SURGERY; BECK DEPRESSION INVENTORY; BINGE EATING DISORDER; BODY WEIGHT; BULIMIA; CALORIC INTAKE; CALORIE; CIRCADIAN RHYTHM; CLINICAL ASSESSMENT; COMORBIDITY; EATING DISORDER; FEEDING BEHAVIOR; HEREDITY; HOSPITALIZATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; NEUROENDOCRINE SYSTEM; NEUROIMAGING; NIGHT EATING SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHLEBITIS; POLYSOMNOGRAPHY; PREVALENCE; QUESTIONNAIRE; REVIEW; SEMI STRUCTURED INTERVIEW; SEROTONINERGIC SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS; TREATMENT DURATION; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 77958609419     PISSN: 11244909     EISSN: 15901262     Source Type: Journal    
DOI: 10.1007/BF03325274     Document Type: Review

References (69)

1. Stunkard AJ, Grace WJ, Wolff HG. The night-eating syndrome: A pattern of food intake among certain obese patients. Am J Med 1955; 19: 78-86.
2. Stunkard AJ. The Pain of Obesity. Boulder, Bull Publishing Co, 1976, pp 41-63.
3. O'Reardon JP, Ringel BL, Dinges DF, et al. Circadian eating and sleeping patterns in the night eating syndrome. Obes Res 2004; 12: 1789-96.
4. Allison KC, Lundgren JD, O'Reardon JP, et al. Proposed diagnostic criteria for night eating syndrome. Int J Eat Disord 2010; 43: 241-7.
5. Lamerz A, Kuepper-Nybele J, Bruning N, et al. Prevalence of obesity, binge eating and night eating in a cross-sectional field survey of 6-year-old children and their parents in a German urban population. J Child Psychol Psychiatry 2005; 46: 385-93. (Pubitemid 40514958)
6. Colles SL, Dixon JB, O'Brian PE. Night Eating Syndrome and nocturnal snacking associated with obesity, binge eating, and psychology. Int J Obes 2007; 31: 1722-30.
7. Rand CSW, Macgregor MD, Stunkard AJ. The night eating syndrome in the general population and among post-operative obesity surgery patients. Int J Eat Disord 1997; 22: 65-9.
8. Striegel-Moore RH, Franko DL, Thompson D, et al. Night eating: Prevalence and demographic correlates. Obes Res 2006; 141: 139-47. (Pubitemid 46214784)
9. Allison KC, Crow S, Reeves RR, et al. The prevalence of binge eating disorder and night eating syndrome in adults with type 2 diabetes mellitus. Obesity 2007; 15: 1285-91.
10. Morse SA, Ciechanowski PS, Katon WJ, et al. Isn't this just bedtime snacking? The potential adverse effects of night-eating symptoms on treatment adherence and outcomes in patients with diabetes. Diabetes Care 2006; 29: 1800-4.
11. Adami GF, Campostano A, Marinari GM, et al. Night eating in obesity: a descriptive study. Nutrition 2002; 18: 587-9. (Pubitemid 34687095)
12. Ceru-Björk C, Andersson I, Rössner S. Night Eating and nocturnal eating - two different or similar syndromes among obese patients? Int J Obes 2001; 25: 365-72.
13. Stunkard A, Berkowitz R, Wadden T, et al. Binge eating disorder and the night-eating syndrome. Int J Obes 1996; 20: 1-6. (Pubitemid 26025041)
14. Allison KC, Wadden TA, Sarwer DB, et al. Night eating syndrome and binge eating disorder among persons seeking bariatric surgery: prevalence and related features. Obesity 2006; 4: 77S-82S.
15. Lundgren JD, Allison KC, Crow S, et al. Prevalence of the night eating syndrome in a psychiatric population. Am J Psychiatry 2006; 163: 156-8. (Pubitemid 43050120)
16. Tholin S, Lindroos AK, Tynelius P, et al. Prevalence of night eating in obese and non-obese twins. Obesity (Silver Spring) 2009; 17: 1050-5. Epub 2009 Feb 19.
17. Napolitano MA, Head S, Babyak MA, et al. Binge eating disorder and night eating syndrome: Psychological and behavioral characteristics. Int J Eat Disord 2001; 30: 193-203. (Pubitemid 32673062)
18. Jarosz PA, Dobal MT, Wilson FL, et al. Disordered eating and food cravings among urban obese African American women. Eat Behav 2007; 8: 374-81.
19. Allison KC, Lundgren JD, O'Reardon JP, et al. The Night Eating Questionnaire (NEQ): psychometric properties of a measure of severity of the Night Eating Syndrome. Eat Behav 2008; 9: 62-72. Epub 2007 Mar 28.
20. Lundgren J, Allison KC, Stunkard AJ. Familial aggregation in the night eating syndrome. Int J Eat Disord 2006; 39: 516-8. (Pubitemid 44232271)
21. Rasmussen F, Tholin F, Tynelius PO. Importance of genes and environmental factors for symptoms of night eating among 5209 pairs of twins from Sweden (Abstract). Int J Obes 2007; T4: PO, 21.
22. Birketvedt G, Florholmen J, Sundsfjord J, et al. Behavioral and neuroendocrine characteristics of the night-eating syndrome. JAMA 1999; 282: 657-63. (Pubitemid 29384154)
23. Rogers NL, Dinges DF, Allison KC, et al. Assessment of sleep in women with Night Eating Syndrome. Sleep 2006; 29: 814-9.
24. Goel N, Stunkard AJ, Rogers NL, et al. Circadian rhythm profiles in women with night eating syndrome. J Biol Rhythms 2009; 24: 85-94.
25. Allison KC, O'Reardon JP, Stunkard AJ, et al. Characterizing the night eating syndrome. Obes Res 2001; 9: 93S.
26. Allison KC, Ahima RS, O'Reardon JP, et al. Neuroendocrine profiles associated with energy intake, sleep and stress in the Night Eating Syndrome. J Clin Endocrinol Metab 2005; 90: 6214-7.
27. Takeda E, Terao J, Nakaya Y, et al. Stress control and human nutrition. J Med Invest 2004; 51: 139-45.
28. Geliebter A, Gluck ME, Yahav E. Cortisol following a stress test and dexamethasone suppression test (DST) in relation to psychopathology in the night eating syndrome (Abstract). Appetite 2002; 39: 77.
29. Birketvedt GS, Sundsfjord J, Florholmen JR. Hypothalamic-pituitary- adrenal axis in the night eating syndrome. Am J Phys Endocrinol Metab 2002; 282: E366-9. (Pubitemid 34657252)
30. Beck AT, Ward C, Mendelson M. Beck Depression Inventory (BDI). Arch Gen Psychiatry 1961; 4: 561-71.
31. Lundgren JD, Newberg AB, Allison KC, et al. SPECT imaging of serotonin transporter binding in patients with night eating syndrome. Psychiatr Res Neuroimaging 2007; 162: 214-20.
32. Lundgren JD, Amsterdam J, Newberg A, et al. Differences in serotonin transporter binding affinity in patients with major depressive disorder and night eating syndrome. Eat Weight Disord 2009; 14: 45-50.
33. Jeanrenaud B, Rohner-Jeanrenaud F. CNS-periphery relationships and body weight homeostasis: influence of the glucocorticoid status. Int J Obes Relat Metab Disord 2000; 24 (Suppl 2): S74-6.
34. Dallman MF, Warne JP, Foster M, et al. Glucocorticoids and insulin both modulate caloric intake through actions on the brain. J Physiol 2007; 583: 431-6. (Pubitemid 47343481)
35. Lu XY, Shieh KR, Kabbaj M, et al. Diurnal rhythm of agouti-related protein and its relation to corticosterone and food intake. Endocrinology 2002; 143: 3905-15. (Pubitemid 35244370)
36. Akana SF, Strack AM, Hanson ES, et al. Interactions among chronic cold, corticosterone and puberty on energy intake and deposition. Stress 1999; 3: 131-46.
37. Dallman MF, Akana SF, Pecoraro NC, et al. Glucocorticoids, the etiology of obesity and the metabolic syndrome. Curr Alzheimer Res 2007; 4: 199-204. (Pubitemid 46562395)
38. Zakrzewska KE, Cusin I, Stricker-Krongrad A, et al. Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat. Diabetes 1999; 48: 365-70. (Pubitemid 29061112)
39. Cusin I, Rouru J, Rohner-Jeanrenaud F. Intracerebroventricular glucocorticoid infusion in normal rats: induction of parasympathetic-mediated obesity and insulin resistance. Obes Res 2001; 9: 401-6. (Pubitemid 33603866)
40. Glasow A, Haidan A, Hilbers U, et al. Expression of Ob receptor in normal human adrenals: differential regulation of adrenocortical and adrenomedullary function by leptin. J Clin Endocrinol Metab 1998; 83: 4459-66. (Pubitemid 29100152)
41. Gaillard RC, Spinedi E, Chautard T, et al. Cytokines, leptin, and the hyptothalamo-pituitary-adrenal axis. Ann NY Acad Sci 2000; 917: 647-57.
42. Licinio J, Mantzoros C, Negrao AB, et al. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med 1997; 3: 575-9. (Pubitemid 27198660)
43. Heiman ML, Ahima RS, Craft LS, et al. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997; 138: 3859-63.
44. Oates M, Woodside B, Walker CD. Chronic leptin administration in developing rats reduces stress responsiveness partly through changes in maternal behavior. Horm Behav 2000; 37: 366-76. (Pubitemid 30432355)
45. Bornstein SR, Uhlmann K, Haidan A, et al. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes 1997; 46: 1235-8. (Pubitemid 27271088)
46. Arvaniti K, Huang Q, Richard D. Effects of leptin and corticosterone on the expression of corticotropinreleasing hormone, agouti-related protein, and proopiomelanocortin in the brain of ob/ob mouse. Neuroendocrinology 2001; 73: 227-36. (Pubitemid 32424516)
47. Lu XY, Kim CS, Frazer A, et al. Leptin: a potential novel antidepressant. Proc Natl Acad Sci USA 2006; 103: 1593-8.
48. Lu XY. Role of central melanocortin signaling in eating disorders. Psychopharmacol Bull 2001; 35: 45-65.
49. Barsh GS, Schwartz MW. Genetic approaches to studying energy balance: perception and integration. Nat Rev Genet 2002; 3: 589-600.
50. Ollmann MM, Wilson BD, Yang YK, et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1998; 278: 135-8.
51. Lu XY, Nicholson JR, Akil H, et al. Time course of short-term and long-term orexigenic effects of agouti-related protein (86-132). Neuroreport 2001; 12: 1281-4.
52. Chen AS, Marsh CJ, Trumbauer ME, et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 2000; 26: 97-102.
53. Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-41. (Pubitemid 27180337)
54. Coll AP, Farooqi IS, Challis BG, et al. Proopiomelanocortin and energy balance: insights from human and murine genetics. J Clin Endocrinol Metab 2004; 89: 2557-62.
55. Sutton GM, Perez-Tilve D, Nogueiras R, et al. The melanocortin-3 receptor is required for entrainment to meal intake. J Neurosci 2008; 28: 12946-55.
56. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2002; 301: 386-9. (Pubitemid 36877077)
57. Kendler KS, Kuhn JW, Vittum J, et al. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression. Arch Gen Psychiatry 2005; 62: 529-35. (Pubitemid 40628882)
58. Tauscher J, Pirker W, Williet M, et al. [123I] -β- CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry 2001; 49: 326-32. (Pubitemid 32182362)
59. Kuikka JT, Tammela L, Karhunen L, et al. Reduced serotonin transporter binding in binge eating women. Psychopharmacology 2001; 155: 310-4. (Pubitemid 32477288)
60. Frazer A. Pharmacology of antidepressants. J Clin Psychopharmacol 1997; 17 (Suppl 1): 2S-8S.
61. Clifton PG, Kennett GA. Monoamine receptors in the regulation of feeding behaviour and energy balance. CNS Neurol Disord Drug Targets 2006; 5: 293-312.
62. Sprouse J. Pharmacological modulation of circadian rhythms: a new drug target in psychotherapeutics. Expert Opin Ther Targets 2004; 8: 25-38. (Pubitemid 38240022)
63. Miyaoka T, Yasukawa R, Tsubouchi K, et al. Successful treatment of nocturnal eating/drinking syndrome with selective serotonin reuptake inhibitors. Int Clin Psychopharmacol 2003; 18: 175-7. (Pubitemid 36571064)
64. O'Reardon JP, Stunkard AJ, Allison KC. A clinical trial of sertraline in the treatment of Night Eating Syndrome. Int J Eat Disord 2004; 35: 16-26. (Pubitemid 38040778)
65. O'Reardon JP, Allison KC, Martino NS, et al. A randomized placebo-controlled trial of sertraline in the treatment of the night eating syndrome. Am J Psychiatry 2006; 163: 893-8.
66. Stunkard AJ, Allison KC, Lundgren JD, et al. A paradigm for facilitating pharmacotherapy at a distance: sertraline treatment of the night eating syndrome. J Clin Psychiatry 2006; 67: 1558-72.
67. Guy W. ECDEU assessment manual for psychopharmacology. US Department of Health, Education and Welfare Publication (ADM), 1976, pp 76-338.
68. Wadden TA, Bartlett SJ, Foster GD, et al. Sertraline and relapse prevention training following treatment by very-low-calorie diet: A controlled trial. Obesity Res 1995; 3: 549-57.
69. Goncalves MD, Moore RH, Stunkard AJ, et al. The treatment of night eating: The patient's perspective. Eur Eat Disord Rev 2009; 17: 184-90.